|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-1-17
|
|
pubmed:abstractText |
Peak exercise oxygen consumption is a widely used parameter to determine the need for transplant listing in patients with severe heart failure. Currently, beta-blocker therapy is known to benefit patients with severe heart failure, although it has minimal or no effects on peak exercise oxygen consumption. This raises the hypothesis that peak exercise oxygen consumption transplant-listing criteria are not valid for patients with heart failure who receive beta-blocker therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1053-2498
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
78-86
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12531416-Adrenergic beta-Antagonists,
pubmed-meshheading:12531416-Case-Control Studies,
pubmed-meshheading:12531416-Exercise Test,
pubmed-meshheading:12531416-Exercise Tolerance,
pubmed-meshheading:12531416-Female,
pubmed-meshheading:12531416-Follow-Up Studies,
pubmed-meshheading:12531416-Heart Failure,
pubmed-meshheading:12531416-Heart Transplantation,
pubmed-meshheading:12531416-Humans,
pubmed-meshheading:12531416-Male,
pubmed-meshheading:12531416-Middle Aged,
pubmed-meshheading:12531416-Oxygen Consumption,
pubmed-meshheading:12531416-Retrospective Studies,
pubmed-meshheading:12531416-Survival Rate,
pubmed-meshheading:12531416-Time Factors
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Impact of beta-blocker therapy on functional capacity criteria for heart transplant listing.
|
|
pubmed:affiliation |
Cardiovascular Institute, Pittsburgh, Pennsylvania, USA.
|
|
pubmed:publicationType |
Journal Article
|
